News Minimalist logo

Diabetes medication tirzepatide shows promise for treating sleep disorder

Eastern Mirror — June 22, 2024, 11:00 PM UTC

Summary: Researchers have found tirzepatide, a diabetes medication, to be an effective treatment for Obstructive Sleep Apnea (OSA). The study, published in the New England Journal of Medicine, involved 469 participants with OSA. Tirzepatide led to a significant decrease in breathing interruptions during sleep, improving OSA severity. This breakthrough offers hope for the 936 million OSA patients globally, potentially reducing the need for CPAP therapy.

Full article

Article metrics

The article metrics are deprecated.

I'm replacing the original 8-factor scoring system with a new and improved one. It doesn't use the original factors and gives much better significance scores.

Timeline:

  1. [4.6]
    New drug tirzepatide improves sleep apnea, weight loss in trials (News-Medical.Net)
    82d 9h
    Source
  2. [4.6]
    First drug therapy for sleep apnoea: tirzepatide for OSA (Health Tech World)
    84d 8h
    Source
  3. [2.9]
    Diabetes, obesity drugs can treat severe sleep apnoea (Times Now)
    84d 14h
    Source
  4. [3.7]
    Weight-loss drug Zepbound helps resolve sleep apnea in trials (GMA News Online)
    86d 15h
    Source
  5. [3.3]
    Weight-loss drug Zepbound improves sleep apnea in trials (XM)
    86d 18h
    Source
  6. [4.2]
    Tirzepatide may be first drug to treat sleep apnoea (The Guardian)
    86d 21h
    Source
  7. [2.9]
    Eli Lilly expects FDA decision on Zepbound for sleep apnea (CNBC)
    86d 21h
    Source